polyglucosamine
Small moleculeexperimental
Clinical trial activity
4 trials · 6 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
1
Earliest trial started Nov 1, 2009 (NCT02529631)
Timeline
2010s
- Jan 1, 2017
Earliest Phase 1 Sponsor(trial)
Indications
Approved for
Mechanism of action
- Fatty acidsBINDING AGENT
Fatty acids binding agent
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- polyglucosamine
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05022732 | N/A | May 5, 2020 | Fondazione Casemiro Mondino, University of Pavia |
| NCT04375696 | Phase 4 | Apr 24, 2020 | Certmedica International GmbH, University of Pavia |
| NCT03309358 | Phase 1 | Sep 28, 2017 | Synspira, Inc. |
| NCT02529631 | N/A | Nov 1, 2009 | Certmedica International GmbH, CorCon, Diabetological centre, Dreieich, Germany |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (6)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Certmedica International GmbH | For profit | 2 | 2 | 2 | 2009 |
| University of Pavia | Academic/Hospital | 2 | 1 | 2 | 2020 |
| CorCon | For profit | 1 | 0 | 1 | 2009 |
| Diabetological centre, Dreieich, Germany | Academic/Hospital | 1 | 0 | 1 | 2009 |
| Fondazione Casemiro Mondino | Academic/Hospital | 1 | 0 | 1 | 2020 |
| Synspira, Inc. | For profit | 1 | 1 | 1 | 2017 |
6 organizations
Page 1 / 1